Murphy Middleton Hinkle & Parker Inc. Acquires New Stake in AdvanSix $ASIX

Murphy Middleton Hinkle & Parker Inc. bought a new position in shares of AdvanSix (NYSE:ASIXFree Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 40,568 shares of the company’s stock, valued at approximately $702,000.

Other institutional investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC boosted its stake in AdvanSix by 1,145.9% during the 4th quarter. SG Americas Securities LLC now owns 67,812 shares of the company’s stock valued at $1,173,000 after purchasing an additional 62,369 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of AdvanSix by 6.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 72,116 shares of the company’s stock worth $1,398,000 after buying an additional 4,367 shares in the last quarter. CIBC Private Wealth Group LLC raised its stake in shares of AdvanSix by 27,537.5% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 2,211 shares of the company’s stock worth $43,000 after buying an additional 2,203 shares in the last quarter. Verition Fund Management LLC lifted its holdings in shares of AdvanSix by 186.5% in the third quarter. Verition Fund Management LLC now owns 31,031 shares of the company’s stock valued at $601,000 after buying an additional 20,199 shares during the period. Finally, Qube Research & Technologies Ltd boosted its stake in AdvanSix by 24.8% during the third quarter. Qube Research & Technologies Ltd now owns 69,245 shares of the company’s stock valued at $1,342,000 after buying an additional 13,754 shares in the last quarter. 86.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Loop Capital set a $25.00 target price on AdvanSix in a report on Thursday, March 12th. Truist Financial upped their price target on shares of AdvanSix from $19.00 to $20.00 and gave the company a “hold” rating in a report on Monday, February 23rd. Wall Street Zen lowered shares of AdvanSix from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of AdvanSix in a research note on Monday, December 29th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, AdvanSix presently has an average rating of “Hold” and a consensus price target of $25.67.

View Our Latest Stock Analysis on ASIX

AdvanSix Stock Up 5.2%

Shares of NYSE:ASIX opened at $21.31 on Tuesday. The firm has a 50 day simple moving average of $18.39 and a 200 day simple moving average of $18.17. AdvanSix has a 52 week low of $14.10 and a 52 week high of $25.53. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.52 and a current ratio of 1.13. The company has a market cap of $572.58 million, a PE ratio of 11.77 and a beta of 1.66.

AdvanSix (NYSE:ASIXGet Free Report) last posted its quarterly earnings data on Friday, February 20th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. AdvanSix had a net margin of 3.24% and a return on equity of 6.97%. The firm had revenue of $359.95 million for the quarter, compared to analysts’ expectations of $340.85 million. As a group, research analysts expect that AdvanSix will post 4 earnings per share for the current year.

AdvanSix Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were issued a dividend of $0.16 per share. The ex-dividend date was Monday, March 9th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.0%. AdvanSix’s payout ratio is currently 35.36%.

AdvanSix Profile

(Free Report)

AdvanSix, Inc (NYSE: ASIX) is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.

The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.

Read More

Want to see what other hedge funds are holding ASIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdvanSix (NYSE:ASIXFree Report).

Institutional Ownership by Quarter for AdvanSix (NYSE:ASIX)

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.